Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II study

F. Cardenal, M. Domine, A. Carrato, E. Felip, P. Garrido, O. Juan, A. Artal, G. López-Vivanco, M. Balcells, R. Rosell

Research output: Contribution to journalArticleResearch

13 Citations (Scopus)
Original languageEnglish
Pages (from-to)201-207
JournalLung Cancer
Volume39
Issue number2
DOIs
Publication statusPublished - 1 Feb 2003

Cite this

Cardenal, F., Domine, M., Carrato, A., Felip, E., Garrido, P., Juan, O., Artal, A., López-Vivanco, G., Balcells, M., & Rosell, R. (2003). Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II study. Lung Cancer, 39(2), 201-207. https://doi.org/10.1016/S0169-5002(02)00512-3